Our Mission
PeopleBeatingCancer supports an evidence-based integrative approach to cancer care. For most newly diagnosed patients, FDA-approved therapies form the foundation of treatment, while evidence-based complementary therapies may help reduce side effects and improve survivorship.
Click the orange button to the right to learn more.
Tag Archives for " Multiple Myeloma "
Myeloma Antioxidants- Yes or No?
@font-face { font-family: "Courier New"; }@font-face { font-family: "Times"; }@font-face { font-family: "Wingdings"; }@font-face { font-family: "Cambria"; }p.MsoNormal, li.MsoNormal, div.MsoNormal
Continue readingMyeloma Chemotherapy – Antioxidants Enhance Action
Much debate has focused on whether antioxidants interfere with the efficacy of cancer chemotherapy. The objective of this study is to systematically review the randomized, controlled clinical trial evidence
Continue readingD-RVD vs. RVD as Myeloma Induction
D-VRD vs. RVD as myeloma induction therapy. Do you care? Why or why not? Both chemo combinations are effective. However, the FDA says that there is one single standard-of-care therapy plan for all newly
Continue readingSecretory vs. Non-Secretory Myeloma
What is non-secretory myeloma? We’ve all heard and read these labels but you may not know what they mean. So what is the difference? Secretory myeloma is the regular, old, multiple myeloma. Plasma
Continue readingEnd Stage Myeloma Selinexor
End stage myeloma occurs when a MM patient reaches multi-drug resistance (MDR). Basically, if you’re a MM patient who has tried and failed all other FDA approved MM therapies then your MM grows
Continue readingStaying Strong: Physical and Mental Strategies for Thriving with Myeloma
Myeloma is an aggressive form of cancer that affects the plasma cells in the bone marrow. This type of cancer is challenging to treat and can cause serious physical and emotional stress. It can be easy
Continue readingMyeloma – Heart Damage Risk 300% Higher!
“The risk (cardiomyopathy) ranged from about 60% higher in ovarian cancer to over 300% higher in multiple myeloma.” Certain multiple myeloma chemotherapy regimens are cardio-toxic (damage your
Continue readingXerostomia-Dry Mouth
“Xerostomia can lead to speech and eating difficulties, halitosis (bad breath), an increase in the number of dental cavities (saliva helps prevent tooth decay), and infections in the mouth, such
Continue readingMyeloma, Zoledronic Acid, Renal, Bone Disease
Osteolytic bone disease and renal dysfunction are complications of multiple myeloma. Zoledronic Acid, used for the prevention and treatment of bone complications, can be nephrotoxic…” According
Continue readingMyeloma – Low Dose, Metronomic
“Metronomic Therapy-Our goal is to significantly reduce tumors, slow or stop their regrowth, and allow a person’s body and immune system time to recover its health and natural abilities to
Continue readingMyeloma Chemo- More Is Not Better-
Two concepts have become standard practice in the treatment of multiple myeloma- low-dose maintenance therapy and metronomic therapy. Myeloma patients tell me over and over again. “My oncologist
Continue readingStem Cells for Chemotherapy-induced Cardiomyopathy?
“A new stem cell therapy significantly improved long-term health outcomes in patients with severe and end-stage heart failure in a study presented at the ACC” I am a long-term survivor of an
Continue reading